Filed Pursuant to Rule 424(b)(3)
Registration Statement No. 333-233396
Prospectus Supplement No. 2
to Prospectus Dated
November 7, 2019
980,557,497 Shares of Common Stock
This prospectus supplement no. 2 (the Supplement) supplements our prospectus dated November 7, 2019 (the Prospectus), which forms
a part of our Registration Statement on Form S-1 (File No. 333-233396), relating to the re-sale of 980,557,497 shares of our
common stock, $0.01 par value per share (the Common Stock) by the selling stockholders identified in the Prospectus.
This Supplement
incorporates into our Prospectus the information contained in our attached Current Reports on Form 8-K, which were filed with the Securities and Exchange Commission on November 26, 2019, December 3,
2019 and December 23, 2019 respectively.
You should read this Supplement in conjunction with the Prospectus, including any supplements and
amendments thereto. This Supplement is qualified by reference to the Prospectus except to the extent that the information in the Supplement supersedes the information contained in the Prospectus.
This Supplement is not complete without, and may not be delivered or utilized except in connection with, the Prospectus, including any supplements and
amendments thereto.
Investing in the Common Stock offered by this Prospectus is speculative and involves a high degree of risk. See Risk
Factors beginning on page 7 of the Prospectus and under similar headings in this Supplement.
NEITHER THE SECURITIES AND EXCHANGE
COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this Prospectus Supplement is December 23, 2019